-transparent.png){kind=logo}
A mouse melanoma (B16) antigen was investigated at a cellular level by three blocking experiments using monoclonal antimelanoma antibodies, soluble melanoma antigen, and enzyme-treated B16 melanoma cells as inhibitors. The activity of antimelanoma cytotoxic T-lymphocytes (CTL) was specifically reduced by addition of the mixture of two monoclonal antimelanoma antibodies, one (M2590) recognizing the cross-species melanoma epitope on GM3(NeuAc) and the other (M562) reactive with the mouse melanoma-specific epitope on protein molecules. The CTL activity was also blocked by GM3 liposome as well as by the soluble antigen. However, 3,000 times more GM3 than the soluble melanoma antigen is required to obtain a similar inhibitory effect. When pronase-treated B16 melanoma cells, which have had protein molecules removed but GM3 left intact on the surface, were used as an inhibitor, their blocking activity was greatly reduced but was still partly observed at a high inhibitor/target ratio. These results indicate that the melanoma antigen is not GM3 itself but is composed of the GM3-protein complex. This finding was also supported by using an interleukin 2-dependent CTL clone whose activity was blocked by both M562 and M2590. Antimelanoma CTL were found to belong to a double-negative T-cell population with Thy-1+, Lyt-2-, L3T4- phenotypes. L3T4+ T-cells were also demonstrated to be necessary for induction of double negative antimelanoma CTL.
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
July 1998,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
October 1987,
Science (New York, N.Y.),
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
January 1986,
Immunogenetics,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
July 1987,
Cellular immunology,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
May 1987,
European journal of immunology,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
April 1986,
Proceedings of the National Academy of Sciences of the United States of America,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
July 1988,
Proceedings of the National Academy of Sciences of the United States of America,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
August 1985,
European journal of immunology,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
December 1982,
European journal of immunology,
K Ono, and
K Takahashi, and
Y Hirabayashi, and
T Itoh, and
Y Hiraga, and
M Taniguchi
December 1996,
The Journal of experimental medicine,
